Corporate Banner
Satellite Banner
Technology Networks Header
Thursday, November 27, 2014
 
Register | Sign in
Home Page>Products
  Product News
Reproducible Medium Throughput Compound Screening
Monday, October 27, 2014
INTEGRA reports on how Pulmocide Ltd. are using a VIAFLO Assist pipetting assistant to enhance the productivity and reproducibility of their screening of novel compounds in a range of biological assays.

Biognosys’ Spectronaut™ Software Now Supports Thermo Scientific™ Proteome Discoverer™ Platform
Monday, October 27, 2014
Proteome Discoverer™ users can generate spectral libraries with Spectronaut™ software.

Agilent Introduces Focused Exome Kit with Unparalleled Coverage, Speed, Flexibility for Disease Research
Monday, October 27, 2014
Solution Ideal for Both High-Throughput and Benchtop Next-Generation Sequencing Applications.

Merck Millipore Introduces PureFlex™ Plus Film
Saturday, October 25, 2014
Single-use process container film for high-volume biopharmaceutical applications.

Clustering Effect Translates into Major Growth for BioPharma Specialist
Saturday, October 25, 2014
Company manages translation and linguistic validation projects.

Tecan’s AC Extraction Plate™ Boosts Productivity for Clozapine Testing
Saturday, October 25, 2014
King’s College Hospital has established a fully automated therapeutic drug monitoring protocol for clozapine.

Easy and Cost-Effective Determination of Dicyandiamide in Milk Powder
Saturday, October 25, 2014
An efficient and simple high-performance liquid chromatography method for the determination of dicyandiamide.

Agilent Introduces SureSelect Focused Exome Kit
Saturday, October 25, 2014
Solution ideal for both high-throughput and benchtop next-generation sequencing applications.

Agilent Introduces Cutting-Edge Accessories to Support LC Workflows
Saturday, October 25, 2014
Improved parts help deliver optimal results.

<< 7 8 9 10 11 12 13 >>
Showing Results 91 - 100 of 10687
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv